Many people believe ckgt.ob will be the sole supplier once the factory comes online. This is simply not true as they have a 5 year commitment. How big is the cig business going to be?
China Kangtai Cactus Agrees 5 Year Deal to Produce its Patented Cactus Cigarettes
China Kangtai Cactus Biotech Inc. (OTC: CKGT) announced that they have signed a five year co-operative production agreement with Jiangsu Nanhuanghai Industry & Commerce Ltd to produce cactus-based cigarettes.
Kangtai is a Chinese based agricultural and processing company, Kantai grows and manufactures of a variety of cactus-based products in China. Their cactus-derived products include nutritious food, a wide variety of beverages, extracts and powders and animal feed.
The newly patented cactus cigarettes are expected to increase sales by approximately $220,000 in the fourth quarter. Under the agreement, China Kangtai will provide its patented technology, raw materials, quality control guidelines and technical support. In return Jiangsu Nanhuanghai will provide processing facilities and production labor. The deal will operate on a fee based system whereby Kantai will pay production fees to Nanhaunghai.
The deal encompasses two varieties of Kantai’s patented cactus cigarettes the low nicotine cactus cigarette contains a small amount of tobacco among its blend of cactus, honeysuckle and ginkgo biloba leaves. This cactus-derived cigarette lowers tar and nicotine content by 70%. Whereas the zero nicotine cigarette is made without any tobacco, according to Kangtai Biotech It offers ‘taste and enjoyment’ that is equivalent to regular cigarettes.
China Kangtai CEO Jinjiang Wang commented on the potential market for the cactus cigarette market, while emphasising the deals ability to ‘fast track’ their products development;
"China has about 390 million smokers, accounting for 30% of global smokers. Our cactus health-preserving cigarette market represents a huge growth opportunity in China. Our strategic alliance with a cooperative cigarette manufacturer enables us to fill orders quickly with short production runs”
China Kangtai Biotech controls over 387 acres of plants and maintains an active R&D group that holds 18 product patents and is seeking another 12. China Kangtai's high-quality "green" products are sold throughout China via a distribution network that covers 12 of China's 23 provinces and two of China's four municipalities.
Register here to be notified of future China Kangtai Cactus Bio-Tech articles. Other China Kangtai Cactus Bio-Tech news
02/09/09
China Kangtai to launch patented cactus-based cigarettes in 2009
More news ?
Investors interested in China Kangtai Cactus Bio-Tech recently viewed
Equatorial Palm Oil (AIM: PAL)
.No investment advice
The Company is a publisher and is not registered with or authorised by the Financial Services Authority (FSA). You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.
You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.
From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.
HomeColumnsCompaniesArchivesSearchAbout UsContact UsRegisterForumsAll SponsorsUK SponsorsNA SponsorsAU SponsorsAll CompaniesCopyright © Proactiveinvestors.cm, 2009. All Rights Reserved. Site designed and maintained by RISK MEDIA
Tehnicom Solutions
Privacy Policy | Terms & Conditions | Copyright Info
AI
